Clinical trials
Phase 3 Essential Hypertension trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis | 5 |
| Sankyo Pharma Gmbh | 5 |
| Daiichi Sankyo | 4 |
| Takeda | 3 |
| Novartis Pharmaceuticals | 2 |
| University of Erlangen-Nürnberg Medical School | 2 |
| Abbott | 1 |
| Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 23 |
| Hypertension | 9 |
| Cardiovascular Diseases | 2 |
| Vascular Diseases | 2 |
| Atherosclerosis | 1 |
| Edema | 1 |
| Hypercholesterolemia | 1 |
| Hypertrophy, Left Ventricular | 1 |
| Renal Insufficiency | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.